You Can Now Get Your Whole Genome Sequenced for Less Than an iPhone

But will people buy it — and is all that genetic information actually worth it?

Emily Mullin
OneZero

--

Images: Veritas

Veritas Genetics is making a big bet that people want to know what’s in their genome.

The Boston-based company, which started offering whole genome sequencing in 2016 for $999 — the first company to do so below four figures — announced today that it is lowering the price to $599. For much less than the price of the latest iPhone model, consumers can get a full readout of their DNA.

Veritas’ move is a clear signal that genetic sequencing technology is getting cheaper as it becomes more automated — but whether people will want to know about the disease risks that may lurk in their genomes is yet to be seen. But Veritas thinks its new price point will be low enough to convince customers that decoding their entire genome is worth it.

“This price point will change the paradigm of how people look at genomics and how they access it,” Mirza Cifric, CEO of Veritas, told OneZero.

Whole genome sequencing is the process of spelling out a person’s entire DNA sequence, all 6 billion letters. By contrast, most consumer genetic tests, including 23andMe and AncestryDNA, use a less comprehensive technique called…

--

--

Emily Mullin
OneZero

Former staff writer at Medium, where I covered biotech, genetics, and Covid-19 for OneZero, Future Human, Elemental, and the Coronavirus Blog.